Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA063783-04
Application #
2105862
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1993-09-22
Project End
1997-09-29
Budget Start
1996-08-15
Budget End
1997-09-29
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Sidney Kimmel Cancer Center
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92121
Hayakawa, Jun; Mittal, Shalu; Wang, Yipeng et al. (2004) Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Mol Cell 16:521-35
Hayakawa, Jun; Depatie, Chantal; Ohmichi, Masahide et al. (2003) The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. J Biol Chem 278:20582-92
Yang, Yong-Min; Bost, Frederic; Charbono, Wilfried et al. (2003) C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma. Clin Cancer Res 9:391-401
Cripe, L D; Gelfanov, V M; Smith, E A et al. (2002) Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation. Leukemia 16:799-812
Gjerset, R; Haghighi, A; Lebedeva, S et al. (2001) Gene therapy approaches to sensitization of human prostate carcinoma to cisplatin by adenoviral expression of p53 and by antisense jun kinase oligonucleotide methods. Methods Mol Biol 175:495-520
Potapova, O; Gorospe, M; Bost, F et al. (2000) c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J Biol Chem 275:24767-75
de Belle, I; Mercola, D; Adamson, E D (2000) Method for cloning in vivo targets of the Egr-1 transcription factor. Biotechniques 29:162-9
Liu, C; Yao, J; Mercola, D et al. (2000) The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251. J Biol Chem 275:20315-23
Gjerset, R A; Lebedeva, S; Haghighi, A et al. (1999) Inhibition of the Jun kinase pathway blocks DNA repair, enhances p53-mediated apoptosis and promotes gene amplification. Cell Growth Differ 10:545-54
de Belle, I; Huang, R P; Fan, Y et al. (1999) p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene 18:3633-42

Showing the most recent 10 out of 22 publications